m. tuberculosis drug resistance gene detection kit (CapitalBio Corporation)
90
Structured Review
CapitalBio Corporation
m. tuberculosis drug resistance gene detection kit
M. Tuberculosis Drug Resistance Gene Detection Kit, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray-based+gene+expression+diagnostic+test/drug+resistance+detection+kit/pmc08214299-249-5-17
Average 90 stars, based on 1 article reviews
M. Tuberculosis Drug Resistance Gene Detection Kit, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray-based+gene+expression+diagnostic+test/drug+resistance+detection+kit/pmc08214299-249-5-17
Average 90 stars, based on 1 article reviews
m. tuberculosis drug resistance gene detection kit - by Bioz Stars,
2026-10
90/100 stars
Images
1) Product Images from "Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Hainan, China: from 2014 to 2019"
Article Title: Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Hainan, China: from 2014 to 2019
Journal: BMC Microbiology
doi: 10.1186/s12866-021-02246-7
Figure Legend Snippet: Evaluation and comparison of drug resistance rate of anti- tuberculosis drugs in 2014–2019
Techniques Used: Comparison
Figure Legend Snippet: Trends of different drug-resistance patterns among 1484 culture-confirmed TB cases in Hainan, 2014 to 2019. In new cases, for INH resistance (χ 2 = 2.813, P = 0.729); for RIF resistance (χ 2 = 3.181, P = 0.672); for MDR-TB (χ 2 = 4.210, P = 0.520); for XDR-TB (χ 2 = 4.383, P = 0.496). In retreatment cases, for INH resistance (χ 2 = 9.512, P = 0.090); for RIF resistance (χ 2 = 14.257, P = 0.014); for MDR-TB (χ 2 = 10.328, P = 0.066); for XDR-TB (χ 2 = 7.670, P = 0.175). Note: *new cases, **retreatment cases. Abbreviation: INH-R, isoniazid resistance; RIF-R, rifampin resistance; MDR-TB, multidrug resistant tuberculosis; XDR-TB, extensively drug resistant tuberculosis
Techniques Used:
Figure Legend Snippet: Evolution of drug resistance mutation sites of Mycobacterium tuberculosis to first-line anti tuberculosis drugs isoniazid and rifampin in 2014–2019
Techniques Used: Mutagenesis
Related Articles
Diagnostic Assay:Article Title: Diagnosis of osteoarticular tuberculosis via metagenomic next-generation sequencing: A case report Article Snippet: .. To verify the mNGS test results, the intra-operative synovial fluid was examined using a variety of validated molecular diagnostic methods for detecting MTB. i) The results of nested PCR targeting the IS6110 gene were positive. ii) PCR and hybridization using the Nested PCR:Article Title: Diagnosis of osteoarticular tuberculosis via metagenomic next-generation sequencing: A case report Article Snippet: .. To verify the mNGS test results, the intra-operative synovial fluid was examined using a variety of validated molecular diagnostic methods for detecting MTB. i) The results of nested PCR targeting the IS6110 gene were positive. ii) PCR and hybridization using the Polymerase Chain Reaction:Article Title: Diagnosis of osteoarticular tuberculosis via metagenomic next-generation sequencing: A case report Article Snippet: .. To verify the mNGS test results, the intra-operative synovial fluid was examined using a variety of validated molecular diagnostic methods for detecting MTB. i) The results of nested PCR targeting the IS6110 gene were positive. ii) PCR and hybridization using the Hybridization:Article Title: Diagnosis of osteoarticular tuberculosis via metagenomic next-generation sequencing: A case report Article Snippet: .. To verify the mNGS test results, the intra-operative synovial fluid was examined using a variety of validated molecular diagnostic methods for detecting MTB. i) The results of nested PCR targeting the IS6110 gene were positive. ii) PCR and hybridization using the Real-time Polymerase Chain Reaction:Article Title: Advances in Diagnostic Assays for Tuberculosis Article Snippet: These include assays launched 20 years ago to assays only recently marketed. table ft1 table-wrap mode="anchored" t5 Table 3. caption a7 Manufacturer (country) Test Market release Fully integrated Dedicated instrument Throughput Detection of drug resistance Intended setting WHO endorsed Regulatory approvals Hologic Genprobe (USA) AMTD test 1993 No Yes 50 tests in 5.5 h No Reference No FDA, CE-IVD Becton Dickinson (USA) BD ProbeTec ET Direct TB Assay 1999 No Yes 150 tests in 8 h No Reference No CE-IVD Hain Lifescience (Germany) GenoType MTBDR plus 2008 No Yes 96 tests per day Yes (MDR) Reference Yes CE-IVD, CFDA Hain Lifescience (Germany) GenoType MTBDR sl 2009 No Yes 96 tests per day Yes (XDR) Reference No CE-IVD Roche (USA) Cobas TaqMan MTB Test 2009 No Yes 44 tests in 3 h No Reference No CE-IVD, Health Canada, FDA? .. Ustar Biotechnologies (China) EasyNAT TB 2009 No No 30 tests per day No Peripheral No CE-IVD CapitalBio (China) other:Article Title: Diagnostic Performance of GeneChip for the Rapid Detection of Drug-Resistant Tuberculosis in Different Subgroups of Patients Article Snippet: Fluorescent intensities were quantified by using the Article Title: Asia emerges as a hotbed of diagnostic innovations for tuberculosis Article Snippet: Article Title: Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Hainan, China: from 2014 to 2019 Article Snippet: This study was based on Drug Susceptibility Assay:Article Title: Hierarchically structured Ag modified nanosilica constructed by micelle modification tactics delivers integrated catalytic and antibacterial activity Article Snippet: The complexity of environmental pollution poses a severe threat to public health, attracting considerable interest in the search for functional nanomaterials for dye removal and direct disinfection together in wastewater.. Herein, we present a deft synthetic strategy for constructing Ag functionalized hierarchically structured nanosilica (Ag modified mesoporous silica/Ag-ms) using micelle termination incorporating Ag ions as a functional metallomicelle template.. The results showed that multiple active Ag cores were decorated into silica nanospheres. Staining:Article Title: Hierarchically structured Ag modified nanosilica constructed by micelle modification tactics delivers integrated catalytic and antibacterial activity Article Snippet: The complexity of environmental pollution poses a severe threat to public health, attracting considerable interest in the search for functional nanomaterials for dye removal and direct disinfection together in wastewater.. Herein, we present a deft synthetic strategy for constructing Ag functionalized hierarchically structured nanosilica (Ag modified mesoporous silica/Ag-ms) using micelle termination incorporating Ag ions as a functional metallomicelle template.. The results showed that multiple active Ag cores were decorated into silica nanospheres. Microarray:Article Title: Hierarchically structured Ag modified nanosilica constructed by micelle modification tactics delivers integrated catalytic and antibacterial activity Article Snippet: The complexity of environmental pollution poses a severe threat to public health, attracting considerable interest in the search for functional nanomaterials for dye removal and direct disinfection together in wastewater.. Herein, we present a deft synthetic strategy for constructing Ag functionalized hierarchically structured nanosilica (Ag modified mesoporous silica/Ag-ms) using micelle termination incorporating Ag ions as a functional metallomicelle template.. The results showed that multiple active Ag cores were decorated into silica nanospheres. |